EICHOR
● Recruiting
Pan Tumor Rollover Study
Condition: Cancer · Sponsor: Bristol-Myers Squibb
About this study
Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.
This description comes directly from the study's public registry record.
Talk to the study team
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
Locations (399)
| Local Institution - 0220 | Huntsville, Alabama, United States | Completed |
| University of Arizona College of Medicine | Tucson, Arizona, United States | Withdrawn |
| Innovative Clinical Research Institute | Lynwood, California, United States | Withdrawn |
| Local Institution | San Francisco, California, United States | Withdrawn |
| Local Institution - 0099 | San Francisco, California, United States | Completed |
| Local Institution - 0233 | Aurora, Colorado, United States | Completed |
| Local Institution - 0095 | New Haven, Connecticut, United States | Withdrawn |
| Local Institution - 0088 | Washington D.C., District of Columbia, United States | Completed |
| Florida Cancer Affiliates | Ocala, Florida, United States | Withdrawn |
| Local Institution | Orlando, Florida, United States | Withdrawn |
| Local Institution - 0024 | Tampa, Florida, United States | Completed |
| Local Institution - 0105 | Chicago, Illinois, United States | Completed |
+ 387 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03899155